| Summary: | Diabetes is a chronical disease that can significantly increase someone�s
risk of having complications. These complications are not only cause the inability
of the body that will affect the quality of life, but also need the big cost. This
research was conducted to analyze the costs and effectiveness of therapies of
outpatient with type 2 diabetes mellitus.
A crosssectional observational method was performed on patient who
were admitted to the Department of Endocrinology of the Sleman Hospital
between December 2010zzxvvh to January 2011. The data were taken in 2 ways:
concurrent and retrospective, with accidental sampling technique. The Subject of
this research are out patient with type 2 diabetes mellitus at RSUD Sleman
Yogyakarta, who have used the antidiabetic therapy for at least three months of
therapy before the quality of life measurement. The Costs that are measured are
direct medical costs, antidiabetic costs, complication costs, laboratory
examination costs, and administration costs. The effectiveness of treatment
parameters is measured based on the percentage of patients with fasting blood
glucose level (GDP) and post-prandial blood glucose (GDPP) which reached the
target in the third month of therapy, and achievement of the quality of life
research subjects.
The Lowest total cost of therapy is on the use of glibenclamide, it was Rp.
49.730,00, the highest total cost of therapy is on the use of insulin, it was Rp
411.045,50. T test results with 95% confidence level indicates that the patient
characteristics and medication adherence complications affect the quality of life of
patients, whereas non-pharmacological therapy (exercise and diet) did not
significantly influence the quality of life of patients. The results of measurements
of quality of life showed metformin achieved the best quality of life than the other
antidiabetic, it was 72.53. Based on the effectiveness of the three parameters
(measurement of quality of life and levels of GDP and GDPP) is noted that
metformin therapy tend to be more effective compared with other antidiabetic
therapies.
|
|---|